Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. - Wikidata - wikimedia - TriplyDB

Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.

Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.

http://www.wikidata.org/entity/Q33285593

about

Recent advances in sialic acid-focused glycomics Purification of derivatized oligosaccharides by solid phase extraction for glycomic analysis BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.Functional network of glycan-related molecules: glyco-net in glycoconjugate data bank.Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.Recent advances in cellular glycomic analyses.High-mannose glycans are elevated during breast cancer progression Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.High-sensitivity analysis of naturally occurring sugar chains, using a novel fluorescent linker molecule.Glycan analysis by reversible reaction to hydrazide beads and mass spectrometry.The sweet and sour of serological glycoprotein tumor biomarker quantification.Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy Glycome characterization of immunoglobulin G from buffalo (Bubalus bubalis) colostrum.Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications.Sialylation determines the nephritogenicity of IgG3 cryoglobulins.Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.Glycome profiling using modern glycomics technology: technical aspects and applications.Glycan labeling strategies and their use in identification and quantification.Relative versus absolute quantitation in disease glycomics.Reversed-phase separation methods for glycan analysis Quantitative glycomics using liquid phase separations coupled to mass spectrometry.Automated, high-throughput serum glycoprofiling platform.Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.Glycosylation specific for adhesion molecules in epidermis and its receptor revealed by glycoform-focused reverse genomics.Label-free quantitation: a new glycoproteomics approach.Quantitative analysis of total serum glycome in human and mouse.Sulfonyl hydrazine-functionalized polymer as a specific capturer of reducing glycans from complex samples for high-throughput analysis by electrospray ionization mass spectrometry.

P2860

Q26866630-D5316CE6-1F75-487F-A496-149AC006D3E9 Q28542008-C1ED6D14-32FB-41B0-9517-7C8A3448AFF4 Q33305172-818E5B76-C3B8-402F-914D-F499C7D44BDB Q33452691-C0C2F3C6-E3D9-444A-AC55-1948895116E1 Q33456015-A9F1AD9C-2191-4F59-8AD7-20F5795094D6 Q33649651-DA45233A-26D9-43D2-A5C2-1D1578DAAE46 Q33753523-6476BFE3-6603-484D-9B67-36CCF7A5A592 Q33995843-18829564-DF5B-4B41-96D2-F059360D79CD Q34048244-ED1966B6-FC6B-46B2-A9BD-BDE7CCF3DAC0 Q34150383-144B06CB-913A-4CF8-86A4-32426BCC8125 Q34580285-36BD7A21-FA55-4E86-B8BB-40CD5DCEA098 Q34597839-C2BB378D-F1F7-4399-B9BA-8928F40F8306 Q35497686-6AD90049-1C3D-4AD2-8407-9EB4F1E4AA6E Q35679876-35458862-B541-4713-83D0-C90E79975209 Q35736606-B73FAE22-F0E6-4060-BE8A-62C0B9BD8AA1 Q35779119-B7C4D22B-38C5-40CD-8B77-DD47F7188A13 Q36352180-BC8A3937-5C98-4F69-BFD8-E5875A8C277A Q36651283-4F1238C0-1C8E-4ADC-9980-817C74E40991 Q36832494-887F63D1-FCE4-43B5-AC40-AE98AF8E59CF Q37686527-FBBC317F-6072-4929-850C-2FB008B859CA Q37708129-85703AA6-1E6F-4410-B26B-60A22952FA38 Q38356585-C4D078EB-62A5-49C4-A0A4-4378A2A4DAE4 Q39020352-BD5A67FE-22BD-41A0-BA71-77A2FB902DCA Q39124498-D563EAD7-63EE-4836-9E40-0B26F8923BF5 Q40720351-EBBFBA70-B53B-4EF7-A6EF-AE81EF47EB8E Q40744914-909305AB-F980-42D0-A886-5D6DC05713EF Q42181384-AC0C747C-C8AD-4721-992B-169F0ED801D6 Q43871500-80209C43-BCF4-49B0-94B3-47EBCDBCDE0F Q46054137-98C85AC4-F15B-4459-B3E8-DF370F326E82 Q46465603-BC12DBC8-2C43-470F-92F8-E96212F3457A Q46577977-7DE30B6C-F25D-4F5E-B1BB-43556B88B3E0

P2860

Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.

http://www.wikidata.org/entity/Q33285593

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@ast

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@en

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@nl

type

label

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@ast

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@en

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@nl

prefLabel

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@ast

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@en

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@nl

P1433

Q33285593-B6F1F227-A8E4-4F04-9F00-07F9230D96C0

P1476

Q33285593-58066F5B-6242-493B-98E5-B6499DE49376

P2093

Q33285593-0AD28CD5-8DBB-48A7-8906-324633156A9B

Q33285593-0EA7025B-17B5-4545-AC8B-1A8E4574B6DB

Q33285593-2FDEAD12-37CE-44CB-A5BA-A0DE16AAA253

Q33285593-60B08B63-5AE3-4AC8-AFFD-B6790E5A3DE6

Q33285593-74857D0F-7101-43AD-98B9-397CE7951622

Q33285593-9D35477D-0CCE-4ECF-B106-30DD4073A957

Q33285593-A8157093-936C-401F-9279-D20FC308D2FF

Q33285593-B4786500-C9E6-4467-A81C-C75CA4F3D215

P2860

Q33285593-045AD109-7715-4376-AD00-1F4538818628

Q33285593-1350DD06-5A81-446E-BA3C-1EEADEE43D23

Q33285593-1E53874A-1DFE-4CE3-80F6-34628465D6F4

Q33285593-2CEBC564-7DD4-49DD-8F9C-B2D35D4C3B66

Q33285593-32D06C69-E225-4653-9272-E665727B31B3

Q33285593-359DC7D7-5794-4525-AFBD-9761A40F616B

Q33285593-3914FB16-BDD0-41B0-831C-814864CF5783

Q33285593-3E6D65AC-D97A-4323-AD0F-E85EDB99D7E9

Q33285593-41835CAE-12C6-4EAF-9C71-7DB0953EB4F6

Q33285593-5D5C99BD-21D2-454A-A994-80B36AA6AAE2

P304

Q33285593-D87F0155-3583-4E09-BDFC-FC5B4E4F6BF3

P31

Q33285593-7047ADF8-1BFD-4769-98EF-6D4C79CC70AB

P356

Q33285593-0A6D7959-4C27-4951-98DC-CAAB4E1FD8C3

P433

Q33285593-A19CEE31-5EBF-4C02-9229-5B1DE07D448F

P478

Q33285593-A1BA208B-CA44-4946-9F8F-3FC33EA1DBC0

P577

Q33285593-52864807-E2CF-4FE2-971C-BE200B7B3658

P5875

Q33285593-585F9D55-00F4-4DE2-A942-FEB0C9D5CCB9

P698

Q33285593-E9FC72DA-BACE-46C8-ADB9-7705C8B24AD6

P356

MCP.T600063-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Quantitative glycomics of huma ...... ocol for liberating N-glycans.

@en

P2093

Akio Takimoto

http://www.w3.org/2001/XMLSchema#string

Jun-ichi Furukawa

http://www.w3.org/2001/XMLSchema#string

Masahiro Ohno

http://www.w3.org/2001/XMLSchema#string

Mika Nakano

http://www.w3.org/2001/XMLSchema#string

Shin-Ichiro Nishimura

http://www.w3.org/2001/XMLSchema#string

Yasuro Shinohara

http://www.w3.org/2001/XMLSchema#string

Yoko Kita

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Miura

http://www.w3.org/2001/XMLSchema#string

P2860

The human plasma proteome: a nonredundant list developed by combination of four separate sources

High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry.

Use of proteomic patterns in serum to identify ovarian cancer.

Unusual N-glycan structures in alpha-mannosidase II/IIx double null embryos identified by a systematic glycomics approach based on two-dimensional LC mapping and matrix-dependent selective fragmentation method in MALDI-TOF/TOF mass spectrometry.

Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry.

Structural characterization of N-glycopeptides by matrix-dependent selective fragmentation of MALDI-TOF/TOF tandem mass spectrometry.

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

Characterization of the low molecular weight human serum proteome.

Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins.

Versatile glycoblotting nanoparticles for high-throughput protein glycomics.

P304

1437-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.T600063-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6311227

http://www.w3.org/2001/XMLSchema#string

P698

17522412

http://www.w3.org/2001/XMLSchema#string